87 related articles for article (PubMed ID: 1660368)
1. Class I anti-arrhythmic drugs: structure and function at the cardiac sodium channel.
Sheldon RS; Duff HJ; Hill RJ
Clin Invest Med; 1991 Oct; 14(5):458-65. PubMed ID: 1660368
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic drugs and the cardiac sodium channel: current models.
Sheldon RS; Hill RJ; Duff HJ
Clin Chem; 1989 May; 35(5):748-54. PubMed ID: 2541948
[TBL] [Abstract][Full Text] [Related]
3. Class I antiarrhythmic drugs: allosteric inhibitors of [3H] batrachotoxinin binding to rat cardiac sodium channels.
Sheldon RS; Duff HJ; Thakore E; Hill RJ
J Pharmacol Exp Ther; 1994 Jan; 268(1):187-94. PubMed ID: 8301556
[TBL] [Abstract][Full Text] [Related]
4. Stereospecific interaction of tocainide with the cardiac sodium channel.
Sheldon RS; Cannon NJ; Nies AS; Duff HJ
Mol Pharmacol; 1988 Mar; 33(3):327-31. PubMed ID: 2451117
[TBL] [Abstract][Full Text] [Related]
5. [New aspects of the molecular effect of anti-arrhythmia agents].
Honerjäger P
Herz; 1990 Apr; 15(2):70-8. PubMed ID: 2160907
[TBL] [Abstract][Full Text] [Related]
6. Models of drug interaction with the sodium channel.
Grant AO
Clin Invest Med; 1991 Oct; 14(5):447-57. PubMed ID: 1660367
[TBL] [Abstract][Full Text] [Related]
7. Molecular properties of brain sodium channels: an important target for anticonvulsant drugs.
Catterall WA
Adv Neurol; 1999; 79():441-56. PubMed ID: 10514834
[TBL] [Abstract][Full Text] [Related]
8. Determinants of stereospecific binding of type I antiarrhythmic drugs to cardiac sodium channels.
Hill RJ; Duff HJ; Sheldon RS
Mol Pharmacol; 1988 Nov; 34(5):659-63. PubMed ID: 2848186
[TBL] [Abstract][Full Text] [Related]
9. [New aspects of the electrophysiologic effect of antiarrhythmic agents].
Antoni H; Weirich J
Herz; 1990 Apr; 15(2):61-9. PubMed ID: 2188893
[TBL] [Abstract][Full Text] [Related]
10. Ring and link requirements for tocainide binding to the class I antiarrhythmic drug receptor on rat cardiac myocytes.
Sheldon RS; Thakore E
J Pharmacol Exp Ther; 1995 Mar; 272(3):1005-10. PubMed ID: 7891310
[TBL] [Abstract][Full Text] [Related]
11. Class I antiarrhythmic drug receptor: biochemical evidence for state-dependent interaction with quinidine and lidocaine.
Hill RJ; Duff HJ; Sheldon RS
Mol Pharmacol; 1989 Jul; 36(1):150-9. PubMed ID: 2546048
[TBL] [Abstract][Full Text] [Related]
12. Binding of [3H]batrachotoxinin A benzoate to specific sites on rat cardiac sodium channels.
Sheldon RS; Cannon NJ; Duff HJ
Mol Pharmacol; 1986 Dec; 30(6):617-23. PubMed ID: 2431264
[TBL] [Abstract][Full Text] [Related]
13. Pyrethroid insecticides: stereospecific allosteric interaction with the batrachotoxinin-A benzoate binding site of mammalian voltage-sensitive sodium channels.
Brown GB; Gaupp JE; Olsen RW
Mol Pharmacol; 1988 Jul; 34(1):54-9. PubMed ID: 2455860
[TBL] [Abstract][Full Text] [Related]
14. State-dependent access to the batrachotoxin receptor on the sodium channel.
De Leon L; Ragsdale DS
Neuroreport; 2003 Jul; 14(10):1353-6. PubMed ID: 12876472
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of the rat cardiac sodium channel by in vivo treatment with a class I antiarrhythmic drug.
Taouis M; Sheldon RS; Duff HJ
J Clin Invest; 1991 Aug; 88(2):375-8. PubMed ID: 1650791
[TBL] [Abstract][Full Text] [Related]
16. Modulation of flecainide's cardiac sodium channel blocking actions by extracellular sodium: a possible cellular mechanism for the action of sodium salts in flecainide cardiotoxicity.
Ranger S; Sheldon R; Fermini B; Nattel S
J Pharmacol Exp Ther; 1993 Mar; 264(3):1160-7. PubMed ID: 8383739
[TBL] [Abstract][Full Text] [Related]
17. Dilazep inhibits binding of batrachotoxin to sodium channels in canine sarcolemmal vesicles.
Chiba K; Hashizume H; Inagaki SI; Abiko Y
Arch Int Pharmacodyn Ther; 1995; 330(2):138-50. PubMed ID: 8861708
[TBL] [Abstract][Full Text] [Related]
18. [Elementary properties and the interaction of single myocardial Na+ channels with antiarrhythmic drugs].
Kohlhardt M
Arzneimittelforschung; 1989 Jan; 39(1A):126-9. PubMed ID: 2541732
[TBL] [Abstract][Full Text] [Related]
19. Mexiletine/quinidine combination therapy: electrophysiologic correlates of anti-arrhythmic efficacy.
Duff HJ; Mitchell LB; Wyse DG; Gillis AM; Sheldon RS
Clin Invest Med; 1991 Oct; 14(5):476-83. PubMed ID: 1660369
[TBL] [Abstract][Full Text] [Related]
20. Vanilloid (subtype 1) receptor-modulatory drugs inhibit [3H]batrachotoxinin-A 20-alpha-benzoate binding to Na+ channels.
Duan Y; Zheng J; Nicholson RA
Basic Clin Pharmacol Toxicol; 2007 Feb; 100(2):91-5. PubMed ID: 17244257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
